Clinerion teams with Medsoft to extend reach in country of Georgia

Clinerion is partnering with electronic health records software company Medsoft to expand its reach in the country of Georgia. (Intrepid Travel)

Clinerion, a Swiss trial recruitment specialist, is partnering with electronic health records software company Medsoft to expand its reach in the country of Georgia.

Medsoft, which is based in Tbilisi, Georgia, has a decade’s worth of experience in eHealth and supports hospitals and other healthcare institutions in the country with technology. The company boasts more than 40 hospitals and medical centers in the country that use its software.

The company’s Medwork hospital information system (HIS) is integrated with the Georgian Ministry of Health, financial systems, and laboratory information systems that provide smoother and more effective information management, according to a release.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Under the partnership, Medsoft will support Clinerion in integrating hospitals in the country into Clinerion’s international network of partner hospitals using its Patient Network Explorer platform. Financial terms of the agreement weren’t disclosed.

“As a HIS provider with a strong presence in Georgia, we consider Medsoft an important partner in our expansion in the region, enabling Clinerion to reach more patients,” Ian Rentsch, Clinerion’s chief executive, said in a statement.

Just last week, Clinerion announced a partnership with Citeline as part of an effort to give clinical researchers a more comprehensive approach to making evidence-based decisions.

Suggested Articles

Scott Gottlieb has slipped right back into his old ways, becoming "special partner" at his old life science VC firm New Enterprise Associates.

Novartis, Otsuka, Pfizer and Sanofi will use technology from Verily’s Project Baseline to carry out clinical studies in various disease areas.

Biotech-CRO hybrid Evotec is continuing its buying and collaborating strategy with its acquisition of U.S. biologics company Just Biotherapeutics.